Cost-Benefit Analysis of 3D Conformal Radiation Therapy: Treatment of Prostate Cancer as a Model

REFERENCES

• ICRU Report 50. Prescribing, recording, and reporting photon beam therapy. Bethesda, MD: International Commission on Radiation Units and Measurements, 1993.
   Google Scholar
• Purdy JA. Defining our goals: volume and dose specification for 3-D conformal radiation therapy. In: Meyer JL, Purdy JA, eds. 3-D conformal radiotherapy. Basel: Karger. Front Radiat Ther Oncol 1996; 29: 24–30.
   Google Scholar
• Huch Boni RA, Boner JA, Debatin JF, et al. Optimization of prostate carcinoma staging: comparison of imaging and clinical methods. Clin Radiol 1995; 50: 593–600.
   PubMed Web of Science ®Google Scholar
• Bates TS, Gillatt DA, Cavanagh PM, Speakman M.Acomparison of endorectal magnetic resonance imaging and transrectal ultrasonography in the local staging of prostate cancer with histopathological correlation. Br J Urol 1997; 79: 927�32.
   Google Scholar
• Tarcan T, Turkeri L, Biren T, Kullo S, Gurmen N, Akdas A. The effectiveness of imaging modalities in clinical staging of localized prostatic carcinoma. Int Urol Nephrol 1996; 28: 773–9.
   Google Scholar
• Roach M III, Faillace-Akazawa P, Malfatti C, Holland J, Hricak H. Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimen-sional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1996; 35: 1011–8.
   Google Scholar
• Logue JP, Sharrock CL, Cowan RA, Read G, Marrs J, Mott D. Clinical variability of target volume description in conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 1998; 41: 929–31.
   PubMed Web of Science ®Google Scholar
• Roeske JC, Forman JD, Mesina CF, et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 1995; 33: 1321–9.
   PubMed Web of Science ®Google Scholar
• Verhey U. Immobilizing and positioning patients for radiother-apy. Semin Radiat Oncol 1995; 5: 100–14.
   PubMedGoogle Scholar
• Lyman JT. Normal tissue complication probabilities: variable dose per fraction. Int J Radiat Oncol Biol Phys 1991; 22:247–50.
   Google Scholar
• Hanks GE, Hanlon AL, Schultheiss TE, et al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 1998; 41: 501–10.
   PubMed Web of Science ®Google Scholar
• Zelefsy MJ, Leibel SA, Gaudin PB, et al. Dose escalation with three-dimensional conformal radiation therapy affects the out-come in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41: 491–500.
   Google Scholar
• Fukunaga-Johnson N, Sandler HM, McLaughlin PW, et al. Results of 3D conformal radiotherapy in the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 1997; 38: 311–7.
   Google Scholar
• Pollack A, Zagars GK, Starkschall G, et al. Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys 1996; 34: 555–64.
   Google Scholar
• Asbell SO, Krall JM, Pilepich MV, et al. Elective pelvic irradiation in Stage A2, B carcinoma of the prostate: analysis of RTOG 77-06. Int J Radiat Oncol Biol Phys 1988; 15: 1307–16.
   PubMed Web of Science ®Google Scholar
• Lawton CA, Won M, Pilepich MV, et al. Long-term treatment sequelae following external beam irradiation for adenocar-cinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys 1991; 21: 935–9.
   PubMed Web of Science ®Google Scholar
• Hanlon AL, Schultheiss TE, Hunt MA, Movsas B, Peter RS, Hanks GE. Chronic rectal bleeding after high dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J Radiat Oncol Biol Phys 1997; 38: 59–63.
   PubMed Web of Science ®Google Scholar
• Cho KH, Lee CKK, Levitt SH. Proctitis after conventional external radiation therapy for prostate cancer: Importance of minimizing posterior rectal dose. Radiology 1995; 195: 699–703.
   Google Scholar
• Pollack A, Zagars GK. External beam radiotherapy dose response of prostate cancer. Int J Radiat Oncol Biol Phys 1997; 39: 1011–8.
   PubMed Web of Science ®Google Scholar
• Corn BW, Hanks GE, Schultheiss TE, Hunt MA, Lee WR, Coia LR. Conformal treatment of prostate cancer with improved targeting: superior prostate-specific antigen response compared to standard treatment. Int J Radiat Oncol Biol Phys 1995; 32: 325–30.
   PubMedGoogle Scholar